Cross-Jurisdictional Regulatory Approvals KPI

What is Cross-Jurisdictional Regulatory Approvals?
The number of regulatory approvals obtained for products or services across different international jurisdictions.

View Benchmarks




Cross-Jurisdictional Regulatory Approvals serve as a critical performance indicator for organizations navigating complex compliance landscapes.

This KPI influences business outcomes such as operational efficiency, risk management, and strategic alignment.

By tracking the time taken to secure necessary approvals across jurisdictions, companies can identify bottlenecks and streamline processes.

Enhanced forecasting accuracy in regulatory timelines can lead to improved project planning and resource allocation.

Ultimately, effective management of this KPI supports better financial health and maximizes ROI metrics.

Organizations that excel in this area often report significant cost savings and faster time-to-market for new initiatives.

Cross-Jurisdictional Regulatory Approvals Interpretation

High values indicate prolonged approval processes, which can delay project timelines and increase costs. Low values suggest efficient navigation of regulatory frameworks, enabling quicker project execution. Ideal targets typically align with industry benchmarks, often aiming for a target threshold of under 30 days for most approvals.

  • <15 days – Exemplary performance; minimal regulatory friction
  • 16–30 days – Acceptable; monitor for potential delays
  • >30 days – Concern; investigate root causes and streamline processes

Cross-Jurisdictional Regulatory Approvals Benchmarks

We have 4 relevant benchmarks in our benchmarks database.

Source: Subscribers only

Source Excerpt: Subscribers only

Additional Comments: Subscribers only

Value Unit Type Company Size Time Period Population Industry Geography Sample Size
Subscribers only days median 2023 new active substances (NASs) pharmaceuticals global (six major agencies)

Unlock this benchmark, plus all 35,548 source-attributed benchmarks with full values, formulas, and citations.

Compare KPI Depot Plans Login

Source: Subscribers only

Source Excerpt: Subscribers only

Additional Comments: Subscribers only

Value Unit Type Company Size Time Period Population Industry Geography Sample Size
Subscribers only days median; IQR 2010–2019 new oncology therapies approved by both regulators pharmaceuticals—oncology United States; European Union 89 therapies

Unlock this benchmark, plus all 35,548 source-attributed benchmarks with full values, formulas, and citations.

Compare KPI Depot Plans Login

Source: Subscribers only

Source Excerpt: Subscribers only

Additional Comments: Subscribers only

Value Unit Type Company Size Time Period Population Industry Geography Sample Size
Subscribers only days threshold national regulatory authority decisions pharmaceuticals and vaccines participating countries

Unlock this benchmark, plus all 35,548 source-attributed benchmarks with full values, formulas, and citations.

Compare KPI Depot Plans Login

Source: Subscribers only

Source Excerpt: Subscribers only

Additional Comments: Subscribers only

Value Unit Type Company Size Time Period Population Industry Geography Sample Size
Subscribers only days threshold marketing authorisation applications pharmaceuticals European Union

Unlock this benchmark, plus all 35,548 source-attributed benchmarks with full values, formulas, and citations.

Compare KPI Depot Plans Login

Common Pitfalls

Many organizations underestimate the complexity of cross-jurisdictional approvals, leading to misaligned expectations and project delays.

  • Failing to engage local regulatory experts can result in misinterpretation of requirements. This oversight often leads to incomplete submissions and extended review periods, negatively impacting timelines.
  • Neglecting to track approval timelines can create a false sense of security. Without monitoring, organizations may miss critical delays that affect project planning and resource allocation.
  • Overlooking stakeholder communication can hinder collaboration. Lack of transparency with internal teams and external regulators often leads to confusion and misalignment on expectations.
  • Inadequate training on regulatory processes can lead to errors. Staff unfamiliar with jurisdictional nuances may struggle to navigate complex requirements, increasing the likelihood of rejections.

KPI Depot is trusted by consulting, strategy, finance, and analytics teams at leading organizations worldwide, including those listed below.

AAMC Accenture AXA Bristol Myers Squibb Capgemini DBS Bank Dell Delta Emirates Global Aluminum EY GSK GlaskoSmithKline Honeywell IBM Mitre Northrup Grumman Novo Nordisk NTT Data PepsiCo Samsung Suntory TCS Tata Consultancy Services Vodafone

Improvement Levers

Improving the efficiency of cross-jurisdictional approvals requires a proactive approach to compliance and communication.

  • Implement a centralized reporting dashboard to track approval timelines. This tool can provide real-time insights and highlight bottlenecks, enabling quicker decision-making.
  • Regularly engage with regulatory bodies to clarify requirements. Building relationships with key contacts can streamline communication and expedite the approval process.
  • Invest in training programs focused on compliance best practices. Equipping staff with the necessary knowledge can reduce errors and improve submission quality.
  • Utilize data-driven decision-making to analyze past approval timelines. Identifying patterns can help forecast future approvals and enhance planning accuracy.

Cross-Jurisdictional Regulatory Approvals Case Study Example

A global pharmaceutical company faced significant delays in obtaining cross-jurisdictional regulatory approvals for its new drug. Over a period of 18 months, approval times exceeded 90 days, jeopardizing their market entry strategy and increasing costs. The company initiated a comprehensive review of its approval processes, identifying key areas for improvement. By establishing a dedicated compliance task force and leveraging business intelligence tools, they streamlined their submission process and enhanced communication with regulatory authorities. Within a year, the average approval time was reduced to 25 days, allowing the company to launch the drug ahead of competitors. This success not only improved their market position but also resulted in a substantial increase in projected revenue.

Related KPIs


What is the standard formula?
Total Number of Regulatory Approvals


Unlock all 35,625 source-attributed benchmarks.
Comparable benchmark data services start at $2,400 per year.
See all 4 benchmarks for Cross-Jurisdictional Regulatory Approvals
Access to 35,625 benchmarks
Access to 24,181 KPIs
Interactive Strategy Maps on every plan
13 attributes per KPI (view)

Compare Plans

KPI Categories

This KPI is associated with the following categories and industries in our KPI database:



KPI Depot takes you from KPI intelligence to finished deliverable. Consultants, strategy teams, FP&A leaders, and analytics teams use it to answer the two hardest questions in performance management, what to measure and what the target should be, and then to produce the scorecard itself.

The difference is intelligence, not just data. Anyone can list metrics. Every KPI in KPI Depot carries 13 practical attributes, from formula and measurement approach to diagnostic questions, risk warnings, and Balanced Scorecard perspective, across 15 corporate functions and 153 industries. And every target you set is grounded in our database of 34,304 source-attributed benchmarks, each detailing metric value, company size, time period, industry, geography, sample size, and source. Benchmark data at this scale is otherwise the domain of research services costing thousands to hundreds of thousands of dollars per year.

When your metrics are selected, KPI Depot finishes the job: export an interactive Strategy Map, a Balanced Scorecard with formulas and tracking columns, or a CSV KPI pack, and go from research to working deliverable in hours instead of weeks.

Formerly the Flevy KPI Library, KPI Depot is trusted by teams at organizations including Accenture, EY, IBM, PepsiCo, Samsung, and Vodafone.

Got a question? Email us at [email protected].

FAQs about Cross-Jurisdictional Regulatory Approvals

What factors influence approval times?

Approval times can be affected by the complexity of the submission, the responsiveness of regulatory bodies, and the completeness of documentation. Additionally, external factors like political changes or public health emergencies may also play a role.

How can technology assist in streamlining approvals?

Technology can automate documentation processes, provide real-time tracking of submissions, and facilitate communication with regulatory agencies. These efficiencies help organizations reduce approval times and improve compliance accuracy.

What are the risks of delayed approvals?

Delayed approvals can lead to increased costs, missed market opportunities, and potential reputational damage. Companies may also face penalties or legal challenges if they fail to comply with regulatory timelines.

How often should approval processes be reviewed?

Regular reviews, ideally quarterly, can help organizations identify inefficiencies and adapt to changing regulatory landscapes. Continuous improvement ensures that processes remain aligned with best practices and compliance requirements.

Can external consultants help with regulatory approvals?

Yes, external consultants can provide valuable expertise and insights into navigating complex regulatory environments. Their experience can help organizations avoid common pitfalls and expedite the approval process.

What role does stakeholder communication play?

Effective stakeholder communication is crucial for aligning expectations and ensuring timely responses. Clear communication helps mitigate misunderstandings and fosters collaboration between internal teams and regulatory bodies.



Each KPI in our knowledge base includes 13 attributes.

KPI Definition

A clear explanation of what the KPI measures

Potential Business Insights

The typical business insights we expect to gain through the tracking of this KPI

Measurement Approach

An outline of the approach or process followed to measure this KPI

Standard Formula

The standard formula organizations use to calculate this KPI

Trend Analysis

Insights into how the KPI tends to evolve over time and what trends could indicate positive or negative performance shifts

Diagnostic Questions

Questions to ask to better understand your current position is for the KPI and how it can improve

Actionable Tips

Practical, actionable tips for improving the KPI, which might involve operational changes, strategic shifts, or tactical actions

Visualization Suggestions

Recommended charts or graphs that best represent the trends and patterns around the KPI for more effective reporting and decision-making

Risk Warnings

Potential risks or warnings signs that could indicate underlying issues that require immediate attention

Tools & Technologies

Suggested tools, technologies, and software that can help in tracking and analyzing the KPI more effectively

Integration Points

How the KPI can be integrated with other business systems and processes for holistic strategic performance management

Change Impact

Explanation of how changes in the KPI can impact other KPIs and what kind of changes can be expected

BSC Perspective

NEW Mapping to a Balanced Scorecard perspective (financial, customer, internal process, learning & growth)


Compare Our Plans


Explore KPI Depot by Function & Industry